Posts by: Timea Polgar, PhD

Timea Polgar, PhD

Timea is a Molecular biologist (MSc) & Computational chemist (MSc, PhD), science liaison, and strategic business development and marketing specialist, with 15 years in pharmaceutical R&D, biotech and scientific software development.

April 19, 2016April 19, 2016

Lung Ultrasound a Possible Alternative to Chest X-ray for Pneumonia Diagnosis in Kids

News, Pneumonia

A new research study demonstrated that lung ultrasound is a novel, efficient and safe option for the diagnosis of pneumonia, representing an alternative to chest X-ray in children. The study, ... Read more

April 15, 2016April 18, 2016

New Lung Transplant Program Opens at Memorial Hermann in Houston

COPD, Cystic Fibrosis, News, Pulmonary Hypertension

Memorial Hermann-Texas Medical Center (TMC) recently announced its new Lung Transplant Program, which offers lung and all solid organ transplants, including the kidney, liver, and heart. The Centers for Disease Control and Prevention ... Read more

April 5, 2016April 6, 2016

Receptor Protein That’s Able to Regulate Allergic Response Is Identified by Scientists

Asthma, News

About 40 percent of people around the world suffer from allergies, or allergic rhinitis. Now a team from Yale University has identified a receptor protein that can control the immune response to ... Read more

April 4, 2016April 4, 2016

Cystic Fibrosis Patients See Potentially Promising Therapies from Proteostasis Therapeutics

Cystic Fibrosis, News

Proteostasis Therapeutics — a pharmaceutical company that develops small molecule drugs for cystic fibrosis (CF) — recently announced the latest pre-clinical results from its first-in-class genotype-agnostic amplifier and a novel corrector of CFTR ... Read more

March 2, 2016March 2, 2016

AffloVest, for Lung and Respiratory Conditions, to Be Made in the USA

Bronchiectasis, Cystic Fibrosis, News

International Biophysics Corp. recently announced that the company will now manufacture its AffloVest in the United States. AffloVest is the first portable High Frequency Chest Wall Oscillation (HFCWO) medical device which can provide critical ... Read more

March 1, 2016March 1, 2016

Lung Disease Patients Need to Work Simple Exercises into Daily Routines, Study Advises

Asthma, Chronic Bronchitis, COPD, Emphysema, News

People with lung disease are advised to do short workouts throughout the day so as to maximize their capacity for physical activity, according to a recent review of studies on ... Read more

February 24, 2016February 24, 2016

Athlete with CTED but Without Pulmonary Hypertension Undergoes Successful Surgery to Remove Fibrotic Clots

News, Pulmonary Hypertension

A recent study discussed a case report of a 43-year-old male athlete with progressive exercise limitation after experiencing a pulmonary embolism (blockage of a pulmonary blood vessel), but without signs ... Read more

February 23, 2016February 23, 2016

New Approach to Cystic Fibrosis Targets Anomaly Protein and Naturally Occurring Substance

Cystic Fibrosis, News

A study from researchers at Eindhoven University of Technology in the Netherlands and McGill University in Montreal, Canada, has demonstrated important progress toward the development of a new drug to battle cystic fibrosis ... Read more

February 18, 2016February 18, 2016

Likely PAH Prognosis May Be Evident in Tissue Phase Mapping of Left Ventricle

News, Pulmonary Hypertension

A tissue phase mapping study reported that left ventricular (LV) function is abnormal in patients with pulmonary arterial hypertension (PAH) and is related to clinical outcomes. The new insights could help ... Read more

February 10, 2016February 18, 2016

In Asthmatic Kids Whose Symptoms Worsen After School Breaks, Common Cold is Likely Culprit

Asthma, News

A new study reported that children with asthma are more often infected with cold viruses soon after they return to school after a seasonal or holiday break. Worsening asthma symptoms result in ... Read more